Current File : /var/www/html/digiprint/public/site/go8r5d/cache/3d3938a099d2b2fc1aa544c0b224757c
a:5:{s:8:"template";s:9437:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>{{ keyword }}</title>
<link href="//fonts.googleapis.com/css?family=Open+Sans%3A300%2C400%2C600%2C700%2C800%7CRoboto%3A100%2C300%2C400%2C500%2C600%2C700%2C900%7CRaleway%3A600%7Citalic&subset=latin%2Clatin-ext" id="quality-fonts-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css"> html{font-family:sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}body{margin:0}footer,nav{display:block}a{background:0 0}a:active,a:hover{outline:0}@media print{*{color:#000!important;text-shadow:none!important;background:0 0!important;box-shadow:none!important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}a[href^="#"]:after{content:""}p{orphans:3;widows:3}.navbar{display:none}}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:62.5%;-webkit-tap-highlight-color:transparent}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}a{color:#428bca;text-decoration:none}a:focus,a:hover{color:#2a6496;text-decoration:underline}a:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}p{margin:0 0 10px}ul{margin-top:0;margin-bottom:10px}.container{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}.row{margin-right:-15px;margin-left:-15px}.col-md-12{position:relative;min-height:1px;padding-right:15px;padding-left:15px}@media (min-width:992px){.col-md-12{float:left}.col-md-12{width:100%}}.collapse{display:none} .nav{padding-left:0;margin-bottom:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:focus,.nav>li>a:hover{text-decoration:none;background-color:#eee}.navbar{position:relative;min-height:50px;margin-bottom:20px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:4px}}@media (min-width:768px){.navbar-header{float:left}}.navbar-collapse{max-height:340px;padding-right:15px;padding-left:15px;overflow-x:visible;-webkit-overflow-scrolling:touch;border-top:1px solid transparent;box-shadow:inset 0 1px 0 rgba(255,255,255,.1)}@media (min-width:768px){.navbar-collapse{width:auto;border-top:0;box-shadow:none}.navbar-collapse.collapse{display:block!important;height:auto!important;padding-bottom:0;overflow:visible!important}}.container-fluid>.navbar-collapse,.container-fluid>.navbar-header{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container-fluid>.navbar-collapse,.container-fluid>.navbar-header{margin-right:0;margin-left:0}}.navbar-brand{float:left;height:50px;padding:15px 15px;font-size:18px;line-height:20px}.navbar-brand:focus,.navbar-brand:hover{text-decoration:none}@media (min-width:768px){.navbar>.container-fluid .navbar-brand{margin-left:-15px}}.navbar-nav{margin:7.5px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:20px}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:15px;padding-bottom:15px}.navbar-nav.navbar-right:last-child{margin-right:-15px}}@media (min-width:768px){.navbar-right{float:right!important}}.clearfix:after,.clearfix:before,.container-fluid:after,.container-fluid:before,.container:after,.container:before,.nav:after,.nav:before,.navbar-collapse:after,.navbar-collapse:before,.navbar-header:after,.navbar-header:before,.navbar:after,.navbar:before,.row:after,.row:before{display:table;content:" "}.clearfix:after,.container-fluid:after,.container:after,.nav:after,.navbar-collapse:after,.navbar-header:after,.navbar:after,.row:after{clear:both}@-ms-viewport{width:device-width}html{font-size:14px;overflow-y:scroll;overflow-x:hidden;-ms-overflow-style:scrollbar}@media(min-width:60em){html{font-size:16px}}body{background:#fff;color:#6a6a6a;font-family:"Open Sans",Helvetica,Arial,sans-serif;font-size:1rem;line-height:1.5;font-weight:400;padding:0;background-attachment:fixed;text-rendering:optimizeLegibility;overflow-x:hidden;transition:.5s ease all}p{line-height:1.7;margin:0 0 25px}p:last-child{margin:0}a{transition:all .3s ease 0s}a:focus,a:hover{color:#121212;outline:0;text-decoration:none}.padding-0{padding-left:0;padding-right:0}ul{font-weight:400;margin:0 0 25px 0;padding-left:18px}ul{list-style:disc}ul>li{margin:0;padding:.5rem 0;border:none}ul li:last-child{padding-bottom:0}.site-footer{background-color:#1a1a1a;margin:0;padding:0;width:100%;font-size:.938rem}.site-info{border-top:1px solid rgba(255,255,255,.1);padding:30px 0;text-align:center}.site-info p{color:#adadad;margin:0;padding:0}.navbar-custom .navbar-brand{padding:25px 10px 16px 0}.navbar-custom .navbar-nav>li>a:focus,.navbar-custom .navbar-nav>li>a:hover{color:#f8504b}a{color:#f8504b}.navbar-custom{background-color:transparent;border:0;border-radius:0;z-index:1000;font-size:1rem;transition:background,padding .4s ease-in-out 0s;margin:0;min-height:100px}.navbar a{transition:color 125ms ease-in-out 0s}.navbar-custom .navbar-brand{letter-spacing:1px;font-weight:600;font-size:2rem;line-height:1.5;color:#121213;margin-left:0!important;height:auto;padding:26px 30px 26px 15px}@media (min-width:768px){.navbar-custom .navbar-brand{padding:26px 10px 26px 0}}.navbar-custom .navbar-nav li{margin:0 10px;padding:0}.navbar-custom .navbar-nav li>a{position:relative;color:#121213;font-weight:600;font-size:1rem;line-height:1.4;padding:40px 15px 40px 15px;transition:all .35s ease}.navbar-custom .navbar-nav>li>a:focus,.navbar-custom .navbar-nav>li>a:hover{background:0 0}@media (max-width:991px){.navbar-custom .navbar-nav{letter-spacing:0;margin-top:1px}.navbar-custom .navbar-nav li{margin:0 20px;padding:0}.navbar-custom .navbar-nav li>a{color:#bbb;padding:12px 0 12px 0}.navbar-custom .navbar-nav>li>a:focus,.navbar-custom .navbar-nav>li>a:hover{background:0 0;color:#fff}.navbar-custom li a{border-bottom:1px solid rgba(73,71,71,.3)!important}.navbar-header{float:none}.navbar-collapse{border-top:1px solid transparent;box-shadow:inset 0 1px 0 rgba(255,255,255,.1)}.navbar-collapse.collapse{display:none!important}.navbar-custom .navbar-nav{background-color:#1a1a1a;float:none!important;margin:0!important}.navbar-custom .navbar-nav>li{float:none}.navbar-header{padding:0 130px}.navbar-collapse{padding-right:0;padding-left:0}}@media (max-width:768px){.navbar-header{padding:0 15px}.navbar-collapse{padding-right:15px;padding-left:15px}}@media (max-width:500px){.navbar-custom .navbar-brand{float:none;display:block;text-align:center;padding:25px 15px 12px 15px}}@media (min-width:992px){.navbar-custom .container-fluid{width:970px;padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}}@media (min-width:1200px){.navbar-custom .container-fluid{width:1170px;padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}} @font-face{font-family:'Open Sans';font-style:normal;font-weight:300;src:local('Open Sans Light'),local('OpenSans-Light'),url(http://fonts.gstatic.com/s/opensans/v17/mem5YaGs126MiZpBA-UN_r8OXOhs.ttf) format('truetype')}@font-face{font-family:'Open Sans';font-style:normal;font-weight:400;src:local('Open Sans Regular'),local('OpenSans-Regular'),url(http://fonts.gstatic.com/s/opensans/v17/mem8YaGs126MiZpBA-UFW50e.ttf) format('truetype')} @font-face{font-family:Roboto;font-style:normal;font-weight:700;src:local('Roboto Bold'),local('Roboto-Bold'),url(http://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmWUlfChc9.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:900;src:local('Roboto Black'),local('Roboto-Black'),url(http://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmYUtfChc9.ttf) format('truetype')} </style>
</head>
<body class="">
<nav class="navbar navbar-custom" role="navigation">
<div class="container-fluid padding-0">
<div class="navbar-header">
<a class="navbar-brand" href="#">
{{ keyword }}
</a>
</div>
<div class="collapse navbar-collapse" id="custom-collapse">
<ul class="nav navbar-nav navbar-right" id="menu-menu-principale"><li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-169" id="menu-item-169"><a href="#">About</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-121" id="menu-item-121"><a href="#">Location</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-120" id="menu-item-120"><a href="#">Menu</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-119" id="menu-item-119"><a href="#">FAQ</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-122" id="menu-item-122"><a href="#">Contacts</a></li>
</ul> </div>
</div>
</nav>
<div class="clearfix"></div>
{{ text }}
<br>
{{ links }}
<footer class="site-footer">
<div class="container">
<div class="row">
<div class="col-md-12">
<div class="site-info">
<p>{{ keyword }} 2021</p></div>
</div>
</div>
</div>
</footer>
</body>
</html>";s:4:"text";s:8818:"New study on Pfizer, Moderna vaccines and COVID-19 variants. Although there's no … The Pfizer-BioNTech coronavirus vaccine provides strong protection against two concerning variants of the virus, including the one that has most worried scientists because it … (CNN) Vaccine makers Pfizer and Moderna are trying to get out ahead of some of the new coronavirus variants that are causing concern around the world. Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in … Two weeks after the second dose, the Pfizer-BioNTech vaccine was 88% effective against symptomatic disease from the B.1.617 variant first detected in India. https://www.jns.org/pfizer-vaccine-found-effective-against-covid-19-variants The Pfizer and Moderna Covid vaccines should remain highly effective against two coronavirus variants first identified in India, according to new … In April 2021, two more independent studies showed Pfizer was effective against multiple variants. B.1.1.7 is known as the variant first identified in the United Kingdom. The study added the Pfizer vaccine provided 95.3% protection against infection and … Moderna says early trial results show increased immunity against COVID-19 variants first found in Brazil and South Africa among people who took a booster shot or an experimental new vaccine. The Moderna and Pfizer vaccines, like the majority of COVID-19 vaccines being used around the world, train the body to recognize the spike protein that is the outer coating of the coronavirus. (CBS DETROIT) – Pfizer and AstraZeneca’s COVID-19 vaccines were found to be highly effective against new coronavirus variants. In February, Pfizer and BioNTech said they were testing a third dose of their Covid-19 vaccine to better understand the immune response against new variants of the virus. March 9, 2021 -- The Pfizer/ and Moderna vaccines don’t work as well against the coronavirus variant first discovered in South Africa as they … The coronavirus variant first discovered in South Africa is able to evade some of the protection of the Pfizer-BioNTech vaccine, according to a … ISTANBUL (REUTERS) - BioNTech SE said on Thursday (May 20) the Covid-19 vaccine it developed with Pfizer should be roughly as effective against the new coronavirus variant first detected in … This includes variants found in India and England. Researchers found that the Pfizer shot is also highly effective against B.117, the variant first found in the UK, preventing 93 percent of symptomatic cases. New reports suggest the Pfizer and Moderna vaccines for COVID-19 can protect people against new coronavirus variants, including one first seen in South Africa called B.1.351. Pfizer's and AstraZeneca 's COVID-19 vaccines seem to work against a variant first found in India. In February 2021, Pfizer and BioNTech initiated an evaluation of the safety and immunogenicity of a third dose of the Pfizer-BioNTech COVID-19 vaccine to understand the effect of a booster on immunity against COVID-19 caused by the circulating and potential newly emerging SARS-CoV-2 variants. For example, companies like Pfizer are considering adding a third, booster dose to their two-dose Covid-19 vaccine regimen to solidify the response to the new variants. None of those volunteers had received the vaccine, suggesting the shot may protect against the troublesome variant, though it's difficult to draw conclusions because the sample size is small. Two weeks after the second dose, the Pfizer-BioNTech COVID-19 vaccine was 88 percent effective against symptomatic disease from a coronavirus variant first identified in India that is spreading in the United Kingdom and could soon become the dominant strain there, a study by Public Health England found. Pfizer said that among 800 participants enrolled in South Africa, nine COVID-19 cases occurred, six of which were caused by B.1.351 infections. Author: SYLVIA HUI … Pfizer has also shared the most recent data on BNT162b2 mRNA vaccine — the phase 3 clinical trial showing vaccine efficacy six months after the second dose from the pivotal registration trial, as also for variants in vitro neutralization, clinically efficacy data and real-world vaccine effectiveness against emerging variants of SARS-CoV-2. Two doses of the COVID-19 vaccines made by Pfizer-BioNTech or AstraZeneca are "highly effective" against variants first detected in India and the United Kingdom, health officials in England announced Saturday.Why it matters: Some health experts have expressed concerns that contagious new variants could be more resistant against coronavirus vaccines, potentially prolonging … The analysis, carried out between 5 April and 16 May, found the Pfizer vaccine was 88% effective against symptomatic disease from the India variant … The COVID-19 vaccine developed by Pfizer and partnering biotechnology company BioNTech has proven “highly effective” against the coronavirus — including variants — … Researchers in the study found that the Pfizer-BioNTech shot was 88 percent effective at preventing symptomatic cases of COVID-19 resulting from the variant … The study also examined the effectiveness of the Pfizer vaccine against the British variant and, once again, showed that the vaccine works. People who have received two doses of the AstraZeneca or Pfizer/BioNTech COVID-19 vaccines have good protection against the Indian variant of SARS-CoV-2 , according to new UK data. The Pfizer vaccine takes two injections separated weeks apart in order for a recipient to become immunized. Johnson & … In a report, PTI said Pfizer … The Pfizer-BioNTech vaccine is incredibly effective against severe disease caused by two variants, studies say. The Pfizer vaccine was found to be 88% effective at stopping symptomatic disease from the Indian variant two weeks after the second dose, compared with 93% effectiveness against the Kent variant. Pfizer has also reportedly sought fast-track approval of its vaccine. The coronavirus variant discovered in South Africa can break through the protection provided by Pfizer Inc and BioNTech's COVID-19 vaccine to … Pfizer reported its vaccine to be 95% effective against symptomatic disease, while Moderna found nearly the same number, 94.1%. JERUSALEM — The coronavirus variant discovered in South Africa can break through the protection provided by Pfizer Inc. and BioNTech’s COVID-19 vaccine … Pfizer vaccine leader on confronting new coronavirus variants By Meredith Wadman Feb. 3, 2021 , 1:40 PM Science ’ s COVID-19 reporting is supported by the Heising-Simons Foundation. The study, led by researchers from Public Health England (PHE) and published yesterday on … Separately, Pfizer and BioNTech are also "in ongoing discussions with regulatory authorities" about potentially testing a vaccine modified to protect against concerning variants in a … The results, released Saturday, are similar to the 93 percent effectiveness against … Pfizer has also reportedly sought fast-track approval of its vaccine. Pfizer-BioNTech Vaccine is Highly Effective Against Variants, Studies Find Two studies showed the vaccine to be more than 95 percent effective at … Two new studies have shown the real-world effectiveness of the Pfizer-BioNTech vaccine rollout against two deadly Covid variants, B.1.1.7 and B.1.351. The Pfizer and AstraZeneca coronavirus vaccines are highly effective against the variant identified in India after two doses, a study has found. One of the people behind the Pfizer-BioNTech COVID-19 vaccine says he has yet to see any evidence that emerging variants of the disease have found a … READ MORE: Dr. Jill Biden To Visit Michigan This Week Pfizer’s vaccine was at least 88 percent effective in preventing symptomatic COVID-19 cases. The Pfizer vaccine is about 75% effective against the India variant. The Covid-19 vaccine from Pfizer and BioNTech appears to protect against viruses carrying at least one of the key mutations found in two coronavirus variants that are … Pfizer's vaccine (BNT162b2) and Moderna's vaccine (mRNA1273) are both able to neutralize the spike proteins on the B.1.617 and B.1.618 variants Dr … WASHINGTON - The Pfizer and Moderna COVID-19 vaccines should remain highly effective against two coronavirus variants first identified in … JERUSALEM — The coronavirus variant discovered in South Africa can break through the protection provided by Pfizer Inc and BioNTech’s COVID-19 vaccine to … (AP Photo/Ted S. Warren, File) A study has found that two doses of the Pfizer/BioNTech or the Astra/Zeneca vaccine protect against the COVID-19 variant first detected in India and the one first found in the United Kingdom. ";s:7:"keyword";s:23:"pfizer vaccine variants";s:5:"links";s:1128:"<a href="http://digiprint.coding.al/site/go8r5d/clutch-celebration-%3A-fifa-21">Clutch Celebration : Fifa 21</a>,
<a href="http://digiprint.coding.al/site/go8r5d/stock-market-investigation">Stock Market Investigation</a>,
<a href="http://digiprint.coding.al/site/go8r5d/lower-mississippi-river-forecast-center">Lower Mississippi River Forecast Center</a>,
<a href="http://digiprint.coding.al/site/go8r5d/microwave-sausage-and-egg-muffin">Microwave Sausage And Egg Muffin</a>,
<a href="http://digiprint.coding.al/site/go8r5d/marakkar-release-date-postponed">Marakkar Release Date Postponed</a>,
<a href="http://digiprint.coding.al/site/go8r5d/grant-jordan-football">Grant Jordan Football</a>,
<a href="http://digiprint.coding.al/site/go8r5d/loveforlandlords-satire">Loveforlandlords Satire</a>,
<a href="http://digiprint.coding.al/site/go8r5d/shandon-bird-nest-coupon">Shandon Bird Nest Coupon</a>,
<a href="http://digiprint.coding.al/site/go8r5d/swertres-summary-result">Swertres Summary Result</a>,
<a href="http://digiprint.coding.al/site/go8r5d/dark-mode-in-google-photos-android-8">Dark Mode In Google Photos Android 8</a>,
";s:7:"expired";i:-1;}
Mini Shell